MYOTONIC DYSTROPHY TYPE 1 (DM1)
Clinical trials for MYOTONIC DYSTROPHY TYPE 1 (DM1) explained in plain language.
Never miss a new study
Get alerted when new MYOTONIC DYSTROPHY TYPE 1 (DM1) trials appear
Sign up with your email to follow new studies for MYOTONIC DYSTROPHY TYPE 1 (DM1), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial tests new IV drug for debilitating muscle disease
Disease control OngoingThis study is testing whether an intravenous drug called AOC 1001 can improve muscle function and control symptoms in adults with myotonic dystrophy type 1 (DM1). Participants receive either the drug or a placebo via infusion every 8 weeks for about a year. The main goal is to se…
Matched conditions: MYOTONIC DYSTROPHY TYPE 1 (DM1)
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Hope for Long-Term muscle disease control
Disease control ENROLLING_BY_INVITATIONThis study aims to learn about the long-term safety and effects of the drug VX-670 in adults with myotonic dystrophy type 1 (DM1). It is an extension study for 44 people who have already completed a previous trial with this drug. The main goal is to monitor participants for side …
Matched conditions: MYOTONIC DYSTROPHY TYPE 1 (DM1)
Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC